No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
459 |
4. Check minimum number of eventsNone |
459 |
5. Include endpointsNone |
459 |
6. Filter based on genotype QC (FinnGen only) |
459 |
Control definitions (FinnGen only)
- Control exclude
- AB1_ZOONOTIC_BACTERIAL
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Tularaemia
based on the number of shared cases.
Similar with more cases:
- Certain zoonotic bacterial diseases
- Certain infectious and parasitic diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4460 | 1976 | 2467 |
| Only index persons | 4103 | 1830 | 2273 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.06 | 0.07 |
| Only index persons | 0.08 | 0.07 | 0.09 |
| Median age at first event (years) | |||
| Whole population | 46.83 | 48.39 | 45.50 |
| Only index persons | 46.01 | 47.63 | 44.71 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 459 | 219 | 240 |
| Unadjusted period prevalence (%) | 0.09 | 0.07 | 0.11 |
| Median age at first event (years) | 50.58 | 47.45 | 53.43 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 404
- Matched controls
- 4040
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A21.9
ICD-10 Finland
Tularaemia, unspecified
3920.1
223.6
195
*
A21.0
ICD-10 Finland
Ulceroglandular tularaemia
1446.8
115.6
107
*
J01MA02
ATC
ciprofloxacin; systemic
5.3
53.9
262
1041
A21.2
ICD-10 Finland
Pulmonary tularaemia
+∞
25.3
24
*
R50.9
ICD-10 Finland
Fever, unspecified
3.8
21.4
101
322
A21.8
ICD-10 Finland
Other forms of tularaemia
+∞
17.8
17
*
0210A
ICD-9 Finland
Tularaemia, Ulceroglandular tularaemia
+∞
15.7
15
*
02100
ICD-8 Finland
Tularaemia, Glanduraris sive ulceroglandularis
+∞
12.6
12
*
A21
ICD-10 Finland
Tularaemia
+∞
11.5
11
*
0219X
ICD-9 Finland
Tularaemia, Unspecified tularaemia
+∞
10.5
10
*
0218X
ICD-9 Finland
Tularaemia, Other specified tularaemia
+∞
10.5
10
*
A98.5
ICD-10 Finland
Haemorrhagic fever with renal syndrome
8.2
10.2
22
28
J17.0*A21.2
ICD-10 Finland
Pneumonia (due to)(in) tularaemia
+∞
9.4
9
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
5.6
8.0
22
41
SPAT1263
SPAT
Sampling
1.8
7.9
177
1198
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.7
7.6
54
221
A21.7
ICD-10 Finland
Generalized tularaemia
+∞
7.3
7
*
WX704
NOMESCO Finland
Intubation
3.3
7.2
35
113
SPAT1324
SPAT
Screening procedure
2.2
6.4
63
308
02107
ICD-8 Finland
Tularaemia, Suspecta
+∞
6.3
6
*
02109
ICD-8 Finland
Tularaemia, Unspecified
+∞
6.3
6
*
B99
ICD-10 Finland
Other and unspecified infectious diseases
6.4
6.2
15
24
SPAT1044
SPAT
Tympanometry
5.7
6.1
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
43
57
8.22
31.09
1.4
1.1
—
—
—
0
0
176
1230
1.70
6.72
4.0
3.2
32.5
31.9
u/l
0.07
169
1174
45
196
2.44
6.67
4.1
2.7
0.4
0.2
e6/l
0.47
45
190
112
691
1.82
6.59
5.3
3.6
148.2
203.1
ng/l
0.24
88
532
115
736
1.75
5.92
1.8
1.7
425.3
6452052.4
pmol/l
0.50
104
620
14
34
4.22
5.39
1.1
1.1
—
—
—
0
0
161
1152
1.61
5.35
2.9
2.6
56.5
57.2
u/l
0.12
153
1065
202
1540
1.56
5.05
6.3
4.6
35.7
35.8
g/l
0.04
188
1440
24
91
2.73
4.73
1.5
1.6
—
—
—
0
0
25
97
2.67
4.72
1.5
1.6
—
—
—
0
0
263
2160
1.51
4.46
5.0
4.9
6.8
6.7
mmol/l
0.14
246
2005
180
1373
1.51
4.32
4.3
3.6
—
—
—
0
0
52
870
0.55
4.14
3.7
2.3
—
—
—
0
0
412
3785
1.86
4.04
17.1
15.9
139.4
139.7
mmol/l
1.35
405
3676
23
93
2.55
4.03
1.5
1.6
—
—
—
0
0
314
2707
1.51
3.98
5.6
4.0
13.4
11.5
mm/h
1.34
306
2487
22
88
2.58
3.94
3.4
4.2
22.1
24.9
mg/l
0.11
16
58
14
43
3.33
3.94
2.9
2.2
13.1
13.2
%
0.13
14
43
412
3798
1.83
3.81
17.8
16.0
4.0
4.0
mmol/l
1.30
405
3686
19
72
2.71
3.78
1.7
1.5
—
—
—
0
0
65
404
1.71
3.64
2.0
1.8
—
—
—
0
0
64
401
1.69
3.49
2.0
1.7
—
—
—
0
0
14
351
0.38
3.38
3.1
2.3
28.4
33.4
u/l
0.70
14
299
279
2405
1.41
3.15
5.4
4.2
861.5
1885.0
e6/l
0.25
17
42
15
56
2.74
3.08
1.4
1.5
—
—
—
0
0
7
210
0.32
3.01
1.3
1.6
—
—
—
0
0
212
1766
1.37
2.83
4.2
3.5
0.0
0.0
estimate
0.00
56
337
82
576
1.52
2.79
2.0
1.9
—
—
—
0
0
20
91
2.25
2.77
3.3
2.2
25.6
24.5
mmol/l
0.27
15
77
318
2846
1.38
2.60
8.8
7.5
75.4
78.0
u/l
0.53
308
2667
138
1084
1.39
2.60
5.2
4.2
21.3
21.0
%
0.09
67
509
12
44
2.77
2.56
1.5
1.9
30.9
33.2
pg
1.02
12
44
5
7
7.21
2.55
1.4
1.4
—
—
—
0
0
213
1801
1.34
2.48
4.2
3.5
0.0
0.0
estimate
0.00
54
322
172
1409
1.35
2.47
3.7
3.6
45.5
38.1
ng/l
0.21
108
982
210
1776
1.34
2.43
5.5
4.8
0.0
0.0
estimate
0.00
55
343
15
64
2.39
2.41
1.4
1.5
—
—
—
0
0
15
64
2.39
2.41
3.1
2.3
14.1
15.9
%
—
9
31
17
78
2.22
2.34
1.1
1.3
282.0
269.8
u/ml
—
9
42
245
2129
1.32
2.31
9.8
8.8
4.3
4.1
e9/l
0.49
232
1870
42
641
0.62
2.30
3.2
2.6
1.1
1.0
e6/l
0.10
28
337
205
1739
1.32
2.28
5.0
4.0
—
—
—
0
0
23
121
1.95
2.25
2.5
1.5
—
132.0
—
0
5
104
798
1.39
2.22
3.9
3.7
1.0
1.0
kg/l
0.04
22
108
8
199
0.39
2.21
5.8
10.9
23.9
24.4
mmol/l
—
8
186
40
612
0.62
2.21
3.4
2.7
0.8
2.4
e6/l
3.05
26
312
11
42
2.66
2.20
1.4
1.2
—
—
—
0
0
417
3957
1.59
2.18
12.0
10.1
28.7
26.9
u/l
0.63
410
3817
9
30
3.04
2.16
1.2
1.1
—
—
—
0
0
396
3726
1.46
2.06
16.9
13.8
26.5
23.3
mg/l
0.90
340
2930
7
20
3.54
2.06
1.7
2.3
—
—
—
0
0
7
20
3.54
2.06
1.3
1.0
—
—
—
0
0
205
1758
1.30
2.05
7.3
6.9
1.2
1.2
mmol/l
0.20
172
1497
17
83
2.09
2.03
1.0
1.3
—
—
—
0
0
10
38
2.67
2.02
2.1
1.3
—
—
—
0
0
7
21
3.37
1.97
1.9
1.3
—
—
—
0
0
25
142
1.80
1.97
2.3
1.8
—
—
—
0
0
58
410
1.47
1.94
5.3
9.2
2.3
0.9
mmol/l
2.30
47
330
112
891
1.34
1.90
2.3
2.0
2.6
3.0
mg/l
1.09
104
755
8
28
2.89
1.87
1.3
1.3
12975.0
19519.1
e6/l
—
8
19
6
18
3.36
1.75
1.3
1.8
513.0
880.3
u/ml
—
6
18
182
1562
1.27
1.74
3.2
2.6
138.7
127.9
ug/l
0.25
167
1438
327
3502
0.77
1.73
14.8
12.8
82.6
82.6
ml/min/173m2
0.01
267
2854
131
1079
1.30
1.73
2.6
2.1
238.5
274.1
u/l
0.12
123
1017
11
49
2.28
1.65
2.1
1.4
—
—
—
0
0
132
1097
1.29
1.62
4.1
4.0
3.3
9.0
mg/mmol
2.51
90
712
219
1937
1.25
1.59
7.0
6.3
11.6
11.4
umol/l
0.06
206
1828
23
137
1.71
1.58
3.0
2.1
3.2
3.7
g/l
1.41
14
102
74
572
1.35
1.52
1.1
1.3
10.8
12.1
u/ml
0.05
24
219
7
27
2.62
1.52
1.9
1.3
—
—
—
0
0
81
635
1.33
1.51
1.6
1.7
1298.5
1148.6
nmol/l
0.85
70
489
21
124
1.73
1.50
4.6
2.2
4873.2
3867.7
u/l
0.07
11
51
378
3578
1.32
1.47
4.3
4.4
5.9
6.0
mmol/l
0.25
361
3271
77
602
1.34
1.47
1.2
1.3
28.2
33.9
iu/ml
0.18
27
198
159
1366
1.25
1.47
5.1
4.8
2.0
2.4
ug/l
0.94
153
1232
21
125
1.71
1.46
3.0
2.2
8.7
10.8
g/l
1.78
15
110
7
29
2.44
1.39
1.3
1.2
—
—
—
0
0
100
817
1.29
1.39
1.8
1.7
1.1
1.3
mg/l
0.28
86
623
297
2743
1.23
1.36
4.3
3.7
14.8
14.8
pmol/l
0.05
282
2465
18
105
1.74
1.35
1.1
1.2
—
—
—
0
0
13
68
1.94
1.34
1.8
1.7
—
—
—
0
0
22
137
1.64
1.32
3.0
2.1
6.8
7.4
g/l
0.56
14
107
22
137
1.64
1.32
3.0
2.1
—
—
—
0
0
18
107
1.71
1.27
1.8
1.8
—
—
—
0
0
8
35
2.31
1.27
1.3
1.1
—
—
—
0
0
260
2381
1.21
1.24
2.8
3.1
—
—
—
0
0
379
3617
1.27
1.18
4.3
4.3
1.4
1.4
mmol/l
0.21
367
3338
22
330
0.65
1.17
3.4
7.5
1.2
1.4
mmol/l
0.80
22
315
35
250
1.43
1.16
2.5
2.4
—
14.8
—
0
14
32
226
1.45
1.13
1.4
1.3
—
41.9
—
0
15
15
88
1.73
1.12
1.5
1.6
—
—
—
0
0
100
840
1.24
1.11
1.7
1.5
19.1
20.6
nmol/l
0.58
93
708
7
31
2.28
1.10
1.3
1.2
—
—
—
0
0
5
21
2.40
1.09
1.2
1.0
—
—
—
0
0
8
41
1.97
1.09
2.1
1.5
11.5
16.1
ug/l
—
8
41
16
97
1.67
1.08
1.4
1.4
—
—
—
0
0
20
129
1.58
1.07
3.3
2.2
2.7
3.1
g/l
0.77
14
104
380
3640
1.26
1.06
4.5
4.4
4.6
4.6
mmol/l
0.16
367
3381
31
424
0.71
1.04
7.6
6.9
—
—
—
0
0
7
34
2.07
1.03
1.0
1.3
—
—
—
0
0
17
107
1.61
1.01
1.5
1.3
—
—
—
0
0
7
37
1.91
0.94
1.3
1.1
—
—
—
0
0
89
1040
0.82
0.91
4.3
2.9
0.1
0.5
e6/l
4.11
76
750
8
42
1.92
0.89
1.5
1.3
—
—
—
0
0
6
30
2.01
0.87
2.2
2.3
648.5
561.9
ml
—
6
17
13
80
1.64
0.85
1.6
1.7
—
—
—
0
0
363
3485
1.20
0.84
4.0
3.9
1.3
1.3
mmol/l
0.36
349
3208
384
3708
1.22
0.82
4.9
4.8
2.8
2.7
mmol/l
0.37
368
3420
95
823
1.19
0.79
1.2
1.2
1.1
1.2
u/ml
0.16
27
227
29
218
1.35
0.77
1.2
1.4
—
—
—
0
0
12
75
1.62
0.75
1.2
1.2
—
—
—
0
0
12
75
1.62
0.75
1.2
1.2
—
1.1
—
0
6
5
24
2.09
0.74
1.0
1.3
—
—
—
0
0
5
24
2.09
0.74
2.0
2.2
768.8
476.5
e6/l
—
5
19
5
24
2.09
0.74
1.0
1.3
—
—
—
0
0
14
92
1.54
0.73
1.5
1.2
—
—
—
0
0
10
60
1.68
0.72
1.2
1.2
67.8
12.0
u/l
—
10
52
62
521
1.22
0.71
2.6
2.2
2.5
2.3
g/l
1.19
57
485
5
26
1.93
0.71
1.0
2.1
—
—
—
0
0
5
26
1.93
0.71
1.0
2.1
—
—
—
0
0
5
26
1.93
0.71
1.0
2.1
—
—
—
0
0
5
26
1.93
0.71
1.0
2.1
—
—
—
0
0
162
1479
1.15
0.70
2.4
2.2
79.2
76.6
nmol/l
0.53
152
1317
10
61
1.65
0.69
1.0
1.1
—
—
—
0
0
11
69
1.61
0.69
1.6
1.5
—
—
—
0
0
7
43
1.64
0.67
1.9
2.2
—
—
—
0
0
13
86
1.53
0.66
2.2
1.7
3.2
4.7
iu/l
—
5
26
10
62
1.63
0.65
3.7
3.2
55.8
57.9
%
—
10
62
52
434
1.22
0.65
3.2
3.0
5.7
9.1
umol/l
1.65
45
386
108
963
1.16
0.65
4.9
3.7
0.0
0.0
estimate
0.69
54
332
58
490
1.21
0.64
1.4
1.4
—
—
—
0
0
20
268
0.73
0.64
2.1
2.8
74.1
68.1
ml/min/173m2
—
9
112
8
49
1.64
0.62
1.8
2.1
—
—
—
0
0
45
373
1.23
0.61
2.8
4.6
4.0
42.9
ug/l
1.12
37
318
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
348
3361
1.15
0.60
5.1
4.4
1.9
1.9
mu/l
0.15
336
3049
38
462
0.81
0.59
2.4
2.2
—
—
—
0
0
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
264
2512
1.12
0.56
3.5
3.2
46.8
52.2
u/l
0.50
246
2354
13
183
0.70
0.56
1.8
1.5
—
—
—
0
0
17
124
1.39
0.56
2.2
3.0
—
—
—
0
0
8
55
1.46
0.56
2.6
1.5
—
—
—
0
0
12
170
0.70
0.54
2.1
2.3
0.6
0.7
%
0.10
12
165
6
41
1.47
0.50
1.2
1.3
—
—
—
0
0
15
110
1.38
0.49
1.3
2.0
—
—
—
0
0
7
45
1.56
0.49
1.0
1.1
—
—
—
0
0
11
76
1.46
0.48
1.7
1.5
16980.8
19628.9
e6/l
0.09
11
56
72
802
0.88
0.43
2.2
3.0
0.6
0.8
ug/l
1.72
47
521
8
57
1.41
0.42
1.1
1.3
—
—
—
0
0
10
70
1.44
0.42
2.9
1.9
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
7.6
—
0
15
0
17
0.00
0.40
0.0
2.3
—
—
—
0
0
347
3382
1.11
0.39
5.9
5.7
40.6
40.0
mmol/mol
0.55
336
3156
5
37
1.36
0.37
1.0
1.0
—
—
—
0
0
5
37
1.36
0.37
3.4
1.5
—
—
—
0
0
13
100
1.31
0.34
1.1
1.4
—
—
—
0
0
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
24
202
1.20
0.31
2.4
1.9
—
—
—
0
0
8
108
0.74
0.29
1.3
1.1
—
—
—
0
0
8
110
0.72
0.29
1.3
1.1
—
—
—
0
0
31
270
1.16
0.29
1.5
1.5
—
—
—
0
0
11
85
1.30
0.28
1.9
1.9
—
—
—
0
0
63
577
1.11
0.28
5.5
3.3
0.8
0.8
mmol/l
0.01
58
541
9
116
0.77
0.27
3.7
1.9
97.7
88.0
%
—
9
111
11
86
1.29
0.26
1.2
1.4
—
—
—
0
0
28
245
1.15
0.25
2.4
2.1
—
—
—
0
0
41
372
1.11
0.22
5.5
3.2
—
—
—
0
0
99
938
1.07
0.22
3.8
2.7
361.6
6427.5
umol/l
3.52
92
807
13
156
0.83
0.21
1.4
1.6
5.7
3.2
mg/l
—
8
112
5
42
1.19
0.21
1.0
1.9
—
—
—
0
0
5
42
1.19
0.21
1.0
1.9
—
—
—
0
0
5
42
1.19
0.21
1.0
1.9
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
425.7
—
0
7
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
20.9
—
0
12
11
134
0.82
0.21
1.4
1.9
—
—
—
0
0
9
113
0.79
0.20
1.0
1.3
—
—
—
0
0
20
228
0.87
0.19
3.3
3.7
4.3
1.6
mmol/l
1.42
14
168
110
1051
1.06
0.19
3.2
3.0
1636.6
1278.2
ng/l
0.28
99
893
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
13
109
1.20
0.18
3.8
2.4
0.4
0.3
u/ml
—
6
62
149
1444
1.05
0.16
2.1
1.9
96.9
95.7
pmol/l
0.10
83
748
36
332
1.09
0.15
4.0
3.4
1.5
1.9
mmol/l
0.34
29
261
10
83
1.21
0.15
1.5
1.3
—
—
—
0
0
39
420
0.92
0.15
2.2
2.0
—
—
—
0
0
9
80
1.13
0.15
1.9
1.4
—
—
—
0
0
43
457
0.93
0.13
14.2
19.8
1.2
1.3
inr
0.44
19
62
163
1593
1.04
0.11
6.1
6.1
1.2
1.2
mmol/l
0.54
150
1450
25
231
1.09
0.11
1.4
1.2
219.7
156.5
iu/ml
0.28
11
93
103
1001
1.04
0.10
1.8
1.6
1.4
1.4
mmol/l
0.35
91
840
5
45
1.11
0.10
2.6
3.3
2.9
3.7
nmol/l
—
5
45
13
145
0.89
0.09
1.5
2.1
—
—
—
0
0
347
3441
1.03
0.09
17.4
14.5
39.7
40.2
%
0.44
205
2537
70
676
1.04
0.09
1.7
1.6
—
—
—
0
0
14
126
1.11
0.09
1.4
1.3
33.2
24.1
iu/l
0.34
14
101
6
54
1.11
0.09
1.2
1.1
—
3.6
—
0
22
52
499
1.05
0.08
2.8
2.2
18.4
24.0
%
2.93
36
433
12
107
1.12
0.08
1.4
1.1
—
—
—
0
0
5
64
0.78
0.08
1.4
1.1
—
—
—
0
0
20
186
1.08
0.07
1.1
1.0
—
—
—
0
0
8
78
1.03
0.07
1.8
1.3
0.6
0.9
nmol/l
—
8
65
121
1192
1.02
0.05
3.7
3.2
2.3
2.4
mmol/l
0.16
111
1048
35
338
1.04
0.04
1.8
1.6
—
—
—
0
0
10
107
0.93
0.02
1.0
2.4
0.0
0.0
g/l
—
10
101
24
244
0.98
0.00
3.0
3.6
5.4
5.1
kpa
0.68
19
222
19
191
0.99
0.00
1.2
1.3
—
—
—
0
0
134
1339
1.00
0.00
4.3
3.0
—
—
—
0
0
6
60
1.00
0.00
1.2
1.5
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
9
99
0.91
0.00
1.0
2.4
0.0
0.0
g/l
—
9
93
8
88
0.91
0.00
2.0
1.8
163.3
224.9
pmol/l
—
8
82
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
5.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
8
79
1.01
0.00
2.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
23.9
—
0
7
5
59
0.85
0.00
1.2
1.5
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
9
97
0.93
0.00
1.0
2.4
0.0
0.0
g/l
—
9
92
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
11.2
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint AB1_TULARAEMIA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_TULARAEMIA | 0.971 [0.78, 1.21] | 0.798 |
| Birth year | 0.996 [0.99, 1.0] | 0.411 |
During the follow-up period (1.1.1998 — 31.12.2019), 131 out of 1400 females with AB1_TULARAEMIA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_TULARAEMIA | 0.804 [0.68, 0.95] | 0.011 |
| Birth year | 0.985 [0.98, 0.99] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 193 out of 1871 males with AB1_TULARAEMIA died.
Mortality risk
Mortality risk for people of age
years, who have AB1_TULARAEMIA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.079% | 0.134% |
| 5 | 0.564% | 0.855% |
| 10 | 1.485% | 2.14% |
| 15 | 2.888% | 4.126% |
| 20 | 4.936% | 7.341% |
Relationships between endpoints
↥Index endpoint: AB1_TULARAEMIA – Tularaemia
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data